JPRN-UMIN000015283招募中未知
Reduced-Fluence Photodynamic Therapy for Central Serous Chorioretinopathy(CSC) and Multifocal Posterior Pigment Epitheliopathy(MPPE) - RFPDT for CSC and MPPE
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional,observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Other associated ocular disease that compromised visual acuity Inability to obtain photographs Significant general disease such as diabetes, liver disease Porphyria
研究者
相似试验
已完成
不适用
Reduced fluence photodynamic therapy combined with intravitreal anti-vascular endothelial growth factor antibody for age-related macular degeneration.Age-related macular degenerationJPRN-UMIN000004562Yamagata University Faculty of Medicine50
已完成
不适用
Photodynamic therapy for the palliation of non-resectable proximal cholangiocarcinomaBile duct tumour, cholangiocarcinomaMalignant neoplasm of liver and intrahepatic bile ductsCancerISRCTN43588830Academic Medical Centre (AMC) (Netherlands)75
尚未招募
不适用
Verteporfin photodynamic therapy for central serous chorioretinopathyCentral serous chorioretinopathyJPRN-UMIN000020677Kansai Medical University30
招募中
不适用
Photodynamic therapy for the palliation of non-resectable proximal cholangiocarcinoma.NL-OMON20863no sponsor75
已完成
不适用
se of Photodynamic therapy in surgical management of Chronic Periodontitis.CTRI/2022/06/043216Dr Mohammad Habib Shahir Chisty10